FluoGuide A/S (STO:FLUO)
Sweden · Delayed Price · Currency is SEK 42.40
+1.50 (3.67%)
May 4, 2026, 5:22 PM CET
FluoGuide Market Cap
FluoGuide has a market cap or net worth of 668.69 million as of May 4, 2026. Its market cap has increased by 33.77% in one year.
Market Cap
668.69M
Enterprise Value
595.49M
Revenue
318.79K
Ranking
n/a
PE Ratio
n/a
Stock Price
42.40
Market Cap Chart
Since May 13, 2019, FluoGuide's market cap has increased from 40.02M to 668.69M, an increase of 1,570.78%. That is a compound annual growth rate of 49.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 668.69M | 19.24% |
| Dec 30, 2025 | 560.78M | 5.17% |
| Dec 30, 2024 | 533.23M | -28.57% |
| Dec 29, 2023 | 746.52M | 68.50% |
| Dec 30, 2022 | 443.04M | -54.38% |
| Dec 30, 2021 | 971.21M | 4.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovis AB (publ.) | 1.28B |
| Xspray Pharma AB | 1.11B |
| Medivir AB | 1.03B |
| SynAct Pharma AB | 984.51M |
| Cantargia AB | 945.22M |
| Infant Bacterial Therapeutics AB | 726.11M |
| Oncopeptides AB | 515.45M |
| Corline Biomedical AB | 411.10M |